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Abstract
Background: Patients at higher than average risk of heritable cancer may process risk information differently than
the general population. However, little is known about clinical, demographic, or psychosocial predictors that may
impact risk perception in these groups. The objective of this study was to characterize factors associated with
perceived risk of developing cancer in groups at high risk for cancer based on genetics or family history.
Methods: We searched Ovid MEDLINE, Ovid Embase, Ovid PsycInfo, and Scopus from inception through April 2009
for English-language, original investigations in humans using core concepts of “risk” and “cancer.” We abstracted
key information and then further restricted articles dealing with perceived risk of developing cancer due to
inherited risk.
Results: Of 1028 titles identified, 53 articles met our criteria. Most (92%) used an observational design and focused
on women (70%) with a family history of or contemplating genetic testing for breast cancer. Of the 53 studies, 36
focused on patients who had not had genetic testing for cancer risk, 17 included studies of patients who had
undergone genetic testing for cancer risk. Family history of cancer, previous prophylactic tests and treatments, and
younger age were associated with cancer risk perception. In addition, beliefs about the preventability and severity
of cancer, personality factors such as “monitoring” personality, the ability to process numerical information, as well
as distress/worry also were associated with cancer risk perception. Few studies addressed non-breast cancer or risk
perception in specific demographic groups (e.g. elderly or minority groups) and few employed theory-driven
analytic strategies to decipher interrelationships of factors.
Conclusions: Several factors influence cancer risk perception in patients at elevated risk for cancer. The science of
characterizing and improving risk perception in cancer for high risk groups, although evolving, is still relatively
undeveloped in several key topic areas including cancers other than breast and in specific populations. Future
rigorous risk perception research using experimental designs and focused on cancers other than breast would
advance the field.
Background
Perceived risk is an important subjective psychological
phenomenon related to threat appraisal that is closely
intertwined with judgments about susceptibility to dis-
ease as well as the probability of benefit from interven-
tions [1]. It remains an integral component of several
theories of health behavior (e.g. the Health Belief Model,
the Precaution Adoption Model, or the Transactional
Model of Stress and Coping) [2]. Thus, risk perception is
an essential component of health behavior in cancer gen-
erally, and in hereditary cancers in particular.
Compared to cancer risk perception in the general
population, experiencing a close family member going
through treatment for cancer or having a known genetic
susceptibility to cancer has life-altering implications,
including how one processes risk information [3]. At-risk
family members or those with known mutations may
have to make important decisions based upon their risk
perceptions, including whether to undergo prophylactic
surgery or subsequent genetic testing, whether to disclose
test results to family members, or whether to participate
in experimental cancer screening (e.g. spiral computed
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shown to both increase and decrease use of preventive
health services and therefore can have significant impli-
cations for the health of those at greater than average
risk of developing cancer.
The existing research on cancer risk perception is
scattered across disciplines (i.e. health services research,
psychooncology, health communication) and across
populations (i.e. cancer patients and the general public)
[2]. In a recent narrative review, Klein and Stefanek dis-
cuss the role of innumeracy, heuristics, motivational fac-
tors, and emotional influences in shaping risk perception
and the implications for cancer risk perception [4]. They
conclude that the psychology of risk perception should
elicit caution among clinicians hoping to accurately con-
vey risk information to patients and call for a research
strategy that spans the fields of medical decision-making
and health communication.
The little remaining empirical literature synthesizing
data regarding cancer risk perception either focuses on
a specific cancer such as breast cancer [5], or describes
interventions to improve risk communication in cancer.
However, little is said about the key clinical, demo-
graphic, or psychosocial predictors that may shape risk
perception [6], all of which are critical factors for tailor-
ing interventions that align patients’ perceptions of risk
with their calculated risk [7].
We undertook a systematic review to rigorously char-
acterize the existing empirical literature on factors that
may influence perceived risk of getting cancer for those
at high risk for cancer in order to form an empirically-
grounded conceptual model for future cancer risk com-
munication research.
Methods
The report of this protocol-driven systematic review
adheres to the Preferred Reporting Items for Systematic
reviews and Meta-Analyses (PRISMA) statement [8].
Protocol details are available upon request.
Eligibility criteria
Studies were eligible if they evaluated associations
between psychosocial, clinical, or demographic factors
and cancer risk perception (or similar terms such as
perceived susceptibility or risk interpretation). Eligible
studies sampled individuals who had one or more
known or suspected non-modifiable risks for hereditary
cancer such as family history or having a positive
genetic test. We excluded studies that sampled exclu-
sively from the general population, average risk popula-
tions, or healthcare providers. We initially included
studies regardless of their design or sample size and
excluded review articles, commentaries, letters not con-
taining original data, and studies that were exclusively
qualitative due to the unfeasibility of data abstraction.
We excluded studies in which the focus was on estab-
l i s h i n ga s s o c i a t i o n so fr i s kf a c t o r sw i t ho u t c o m e so r
behaviors if they did not evaluate predictors of risk per-
ception, interpretation or communication. Similarly, we
excluded educational interventions aimed exclusively at
raising awareness of risk. The characteristics of reviewed
studies are provided in Table 1.
Search strategy
An expert reference librarian designed and conducted
an electronic search strategy with input from study
investigators focused on factors that may influence risk
perception relevant to clinical care. We searched Ovid
MEDLINE, Ovid Embase, Ovid PsycInfo, and Scopus
from inception through April 2009. Only English lan-
guage articles were selected. The core concepts were
risk (MeSH term: risk management) and cancer (MeSH
terms: neoplasms limited to diagnosis, treatment, epide-
miology prognosis, mortality). A series of terms and text
words were added such as patient education, attitude of
patients and health care personnel, educational status,
comprehension, communication in the context of deci-
sion making, choice, preferences, and uncertainty. In
addition, we sought additional references from bibliogra-
phies of eligible studies and content experts. A detailed
list of subject headings and text words is available upon
request.
Assessment of study eligibility
Teams of two reviewers working independently and in
duplicate screened all abstracts and titles and, upon
retrieval of candidate studies, reviewed the full text to
determine eligibility. Disagreements were resolved
through discussion or by arbitration through a third
reviewer. The mean chance-adjusted agreement (kappa)
was 0.70.
Data extraction and synthesis
Teams used standardized forms to extract descriptive,
methodological, and key variable data from all eligible
studies. We used an online reference management sys-
tem for systematic reviews to conduct study selection
and data extraction (SRS 4.0 Mobius Analytics, Ottawa,
Ontario, Canada).
Data collected from the vetted studies included study
design, description of the population, description of the
risk of cancer, analytical techniques, and the theoretical
model tested. From each study, we extracted data regard-
ing the type and strength of associations between psycho-
social, clinical, and/or demographic factors and cancer
risk perception, interpretation and/or communication.
Disagreements between reviewers at this stage were also
resolved by discussion or third-reviewer arbitration.
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in terms of design, population, type of cancer and out-
come measures, and because the review was designed to
generate (not test) hypotheses for future research, we
did not conduct a meta-analysis. Data were tabulated
and categorized according to the factors that affected
risk perception. Narrative synopses describing the tested
associations and the main findings of each study are
presented (Tables 2 & 3). These summaries provided
the empirical basis upon which to build a conceptual
model of factors influencing risk perception in cancer
(Figure 1). Since the included studies were mostly of a
cross-sectional design, the quality of evidence was con-
sidered to be low and at high risk of bias. Therefore we
did not extract data about bias protection measures in
the included studies.
Results
Search results
Our search identified 1028 candidate articles for abstract
review. After screening abstracts (when present), we
excluded 524 articles and retrieved 504 full text articles.
Of these, 184 fulfilled the basic inclusion criteria, but
131 of these were excluded for being exclusively qualita-
tive, addressing risk perception among healthcare provi-
ders, including exclusively patients who already had
cancer or patients with one or more modifiable risks for
cancer, such as smoking. This left 53 articles that met
all inclusion and exclusion criteria (Figure 2). Of those
53 studies, 36 reported participants with elevated risk
who had not undergone genetic testing, and 17 reported
participants who had undergone genetic testing.
Study designs
Table 1 describes the characteristics of the 53 included
studies. Most of the studies (92%) had an observational
study design and only four were experimental.
Study populations
Thirty-eight studies (70%) reported exclusively female
populations, with most (14) of the remaining 16 includ-
ing both genders. The majority (67%) included race
information, but relatively few included non-white
populations and made race-related inferences.
Cancers
The majority of studies (64%) addressed risk perception
of breast cancer, followed by ovarian cancer (often along
with breast cancer risk) (30%), colorectal cancer (23%),
and prostate cancer (4%). Some studies examined multi-
ple cancers.
Risk perception measures & theories
A range of self-reported measures of risk perception
were employed across studies. These measures used a
variety of total item numbers, categorical as well as
Table 1 Description of 53 studies reporting clinical,
demographic or psychosocial factors related to risk
perception in cancer in patients at high risk for cancer
Study Characteristics No. (%) of Studies
Study Design
Experimental (e.g. RCT) 4 (8)
Observational 49 (92)
Cross-sectional 20 (38)
Cohort (retrospective or prospective) 15 (28)
Case-control 4 (8)
Other 10 (19)
Study Population Type
a
Non-Genetic 36 (68)
Genetic 17 (32)
Study Population Characteristics
Gender Representation
Male only 2 (4)
Female only 37 (70)
Mixed 14 (26)
Hispanic ethnicity reported 6 (11)
Race reported
b 36 (67)
White/Caucasian 29 (55)
Black/African American 11 (21)
Asian 6 (11)
American Indian 4 (8)
Hawaiian/ Pacific Islander 3 (6)
Other 17 (31)
Type(s) of Cancer Studied
Breast 34 (64)
Ovarian 16 (30)
Colon 12 (23)
Prostate 2 (4)
Utilized a Theoretical Model of Health
Behavior
7 (13)
Methods of Measuring Risk Perceptions
c
Single Item 37 (70)
Multiple Item 15 (28)
Categorical Measures 35 (66)
Absolute 18 (34)
Comparative 23 (43)
Continuous 25 (47)
Absolute 24 (45)
Comparative 3 (6)
Factors
Clinical 39 (74)
Demographic 16 (30)
Psychosocial 32 (60)
aSome studies included a mix of high risk and average risk/healthy
individuals.
bSome studies included multiple race categories, therefore percentages do
not add to 100.
cSome studies included multiple measures, therefore percentages do not add
to 100.
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Page 3 of 15Table 2 Characteristics of 36 studies reporting clinical, demographic, and/or psychosocial factors related to cancer risk perception in high risk populations
not related to genetic susceptibility testing
First author,
year
Design Cancer
Type
No. sub-
jects
Age (years) Gender
M/F/ M
+F
Tested Factors Influencing Risk Perception Study Synopsis
Clinical Demographic Psychosocial
Haas, 2005
[30]
Observational,
prospective
cohort
Breast 1619 Range 40-74 F Previous childbirth;
+ FH of breast
cancer; BMI; Prior
breast biopsy; Prior
abnormal
mammogram
Age;
Race;
Marital status;
Education level
Studied women’s objective & subjective risks for
developing BC. Younger women overestimated
future BC risk. For women at average BC risk, Asian
Pacific Islanders and women with FH of BC were
more likely to overestimate risk. For women at
high BC risk, younger women were more likely to
accurately perceive risk, and black women (vs.
whites) were less likely to accurately perceive risk.
Rowe, 2005
[31]
Observational,
cross-sectional
Breast 66 Mean 40, Range
25-59
F + FH of breast
cancer
Marital status;
Age; Ethnicity;
Employment
status
Locus of Control;
Breast cancer-
specific control
Studied women with & without FH of BC. Married
women more likely to perceive lower risk of BC
than unmarried women. Women with +FH of BC
perceived higher risk for BC. Internal locus of
control and breast cancer-specific control were
significantly related to women’s perceived
likelihood of remaining free of breast cancer.
Gil, 2003 [47] Observational,
case-control
Breast 84 Range 18-53 F + FH of breast
cancer
Studied distress, perception of BC risk, screening
behaviors, coping skills, personality and quality of
life in Spanish cohort of women with & without
FH of BC. Women with FHBC overestimated their
risk of developing breast cancer.
Lebel, 2003
[34]
Observational,
cross-sectional
Breast 25 Mean 56 F + FH of breast
cancer
Distress;
Venting & denial
coping strategies
Interviewed women with suspicious mammograms
at two time points: immediately after being put on
biopsy wait-list and immediately before biopsy.
Higher perceived risk of malignancy correlated
with distress and use of venting and denial coping
strategies.
Fang, 2003
[48]
Observational,
cross-sectional
Ovarian 76 Mean 42, Range
22-71
F + FH of breast or
ovarian cancer
Studied women with FH of ovarian cancer and
their intention to undergo prophylactic
oophorectomy. Perceived risk levels were not
associated with family history of ovarian cancer or
with family history of breast or ovarian cancer.
Hatcher, 2001
[26]
Observational,
prospective
cohort
Breast 143 Grp 1 median
38, Grp 2
median 40
F Prophylactic
mastectomy status
Studied women with increased risk of developing
BC who were offered bilateral prophylactic
mastectomy and who accepted or declined the
surgery. Acceptors were more likely than decliners
to believe it inevitable that they would develop
breast cancer.
Wellisch, 2001
[49]
Observational,
prospective
cohort
Breast 430 Mean 43, Range
15-78
F Depression status Studied women who presented to a high risk
breast cancer clinic. When estimating their own
risk of developing breast cancer, women scoring
above the CES-D (depression scale) cut-off point
reported higher personal risk estimates than did
women scoring below the cut-off point.
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5Table 2 Characteristics of 36 studies reporting clinical, demographic, and/or psychosocial factors related to cancer risk perception in high risk populations
not related to genetic susceptibility testing (Continued)
Audrain, 1997
[35]
Observational,
prospective
cohort
Breast;
Ovarian
256 Mean 44, Range
21-73
F General distress;
Perceived control
over BC
Studied women with a family history of breast or
ovarian cancer who self-referred for genetic
counseling. Women with higher levels of general
distress had heightened BC PR, though this effect
was moderated by having low perceptions of
control over the development of breast cancer.
Schwartz,
1995 [43]
Observational,
cross-sectional
Ovarian 103 Mean 42, Range
18-74
F Age of diagnosis
for FDR with
ovarian cancer
Intrusive thoughts;
Attentional Style;
Mood disturbance
Studied women with ≥1 FDR with ovarian cancer.
Perceived risk of developing ovarian cancer was
positively correlated with intrusive thoughts and
monitoring, and was negatively correlated with
the age of diagnosis for FDR relative with ovarian
cancer.
Zikmund-
Fisher, 2008
[50]
Experimental Endometrial 631 Mean 59, Range
40-74
F Numeracy Studied women with elevated BC risk. Higher
numeracy was significantly associated with lower
perceived risk of side-effects of tamoxifen,
including endometrial cancer.
Mellon, 2008
[3]
Observational,
familial dyads
Breast;
Ovarian
292 Grp 1 mean 51,
Grp 2 mean 41
F Cancer type of
affected relative;
+FH of cancer
Race;
Age;
Income
Cancer worry Studied dyads of adult breast & ovarian cancer
survivors and their unaffected female relatives.
Caucasian race was associated with higher risk
perceptions, as was income, older age, family
history of cancer, cancer type, and high levels of
cancer worry.
Salsman, 2004
[13]
Observational,
cross-sectional
Ovarian 624 Grp 1 mean 57,
Grp 2 mean 57
F Ovarian cancer
screening status
Studied women undergoing routine transvaginal
sonography screening for ovarian cancer and an
age and education-matched healthy comparison
group. Perceptions of lifetime risk for OC did not
differ between the two groups.
Beebe-
Dimmer, 2004
[40]
Observational,
cross-sectional
Prostate 111 Mean 54, Range
33-78
M + FH of prostate
cancer
Age; Marital
status;
Education
Level
Concern Studied men whose brothers had been diagnosed
with prostate cancer. Men younger than their
affected brother, those with more than one
affected FDR, and those with higher levels of
concern had higher estimates of personal risk for
prostate cancer.
Lobb, 2004
[22]
Observational Breast 158 Grp 1 mean 39,
Grp 2 mean 51
F Receiving written
summary of
genetic counseling
session
Studied women from high risk BC families to
assess how communication regarding genetic
testing for BC was associated with various features
of communication. They found that having
received a written summary of the results was
associated with more accurate risk perception.
Andrykowski,
2002 [36]
Observational,
case-control
Breast 176 Grp 1 mean 44,
Grp 2 mean 45
F Undergoing breast
biopsy
Impact of Events
Scale-intrusion &
avoidance
Studied women with benign breast biopsy and a
healthy comparison group. No differences were
found between groups in perceived risk of BC.
Perceived BC risk was significantly negatively
associated with intrusion and avoidance scores on
the Impact of Events Scale.
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5Table 2 Characteristics of 36 studies reporting clinical, demographic, and/or psychosocial factors related to cancer risk perception in high risk populations
not related to genetic susceptibility testing (Continued)
Royak-Schaler,
2002 [32]
Observational,
cross-sectional
Breast 141 Range 23-81 F > 1 relative with
cancer
Race Having more
complete
discussion with
doctor
Studied FDRs of breast cancer patients. Provider
discussions about FH and personal risk were
accompanied by increases in risk perception and
promoted compliance with screening goals.
Elit, 2001 [25] Observational,
cross-sectional
Ovarian 40 Mean 55 F Oophor-ectomy
status
Studied women with FH of OC who had
undergone prophylactic oophorectomy. Perceived
risk for OC was found to decrease significantly
after surgery.
Vernon, 2001
[27]
Observational Colon 1955 No means given M +FH of polyps or
colon cancer;
Colon screening
exam status
Age;
Education
Level
Degree of familial
support; Cancer
worry
Studied male autoworkers who participated in a
trial to increase CRC screening. At baseline, a
positive association was found between PR of
cancer and positive FH, family support for
screening, and worry about being diagnosed.
Collins, 2000
[39]
Observational Colon 127 Mean 47 M/F Cancer worry Studied patients presenting to a familial CRC clinic.
A significant negative association was found
between PR of bowel cancer and cancer worry.
Erblich, 2000
[38]
Observational,
cross-sectional
Breast 148 Mean 42 F Maternal death due
to BC; Serving as
caregiver for mother
with BC
Anxiety; IES-
intrusion &
avoidance; General
distress; BSI
depression
Studied women with and w/out FDRs with BC.
Among women with FH of BC, perceived risk was
positively correlated with anxiety, intrusion &
avoidance thoughts on the Impact of Events Scale,
and global distress.
Glanz, 1999
[16]
Observational,
cross-sectional
Colon 426 Mean 50, Range
19-84
M/F Education
Level
Awareness of CRC
family history
Studied FDRs of patients with CRC. Being a college
graduate and having an awareness of a relative
with CRC cancer were independently and
positively associated with risk perception.
Zakowski,
1997 [19]
Observational Breast 89 Mean 42, Range
23-55
F Objective cancer
risk; +FH of breast
cancer; Death of
parent to cancer
Age at time of
parent(s)’
death
IES-intrusion &
avoidance
Studied women with and without FH of BC.
Higher PR of BC was found in women with FH of
BC and women whose parent(s) had died of
cancer. Results suggested that high PR predicts
high levels of intrusive thoughts and avoidance
regarding BC.
Stefanek,
1995 [51]
Observational Breast 164 Grp 1 mean 37,
Grp 2 mean 38
F Prophylactic
Mastectomy status
Studied women with ≥1 FDR diagnosed with BC
who underwent prophylactic mastectomy,
expressed an interested in surgery, or did not
express an interest. Women who underwent
surgery had significantly higher perceived risk than
women in the non-interest group.
Lerman, 1994
[28]
Observational,
cross-sectional
Breast Grp 1 n =
179, Grp 2
n = 238,
Grp 3 n =
363
Grp 1 range 30-
75, Grp 2 range
20-75, Grp 3
range 20+
F Age Studied women with a FH of BC presenting to
three different clinics. At one site, women in the
30-34 and 50+ categories were significantly less
likely to perceive themselves as having and
elevated risk than were women in other age
groups. No other significant differences by age
were found in the two other study sites.
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5Table 2 Characteristics of 36 studies reporting clinical, demographic, and/or psychosocial factors related to cancer risk perception in high risk populations
not related to genetic susceptibility testing (Continued)
Bondy, 1992
[52]
Observational,
cross-sectional
Breast 30604 Grp 1: 61% over
age 60, Grp 2:
51% under age
50
F Objective risk
based on Gail
model; Degree of
FH
Studied women with and w/out FDRs affected by
BC. Women with the highest relative risk scores for
breast cancer (based on the Gail model) more
likely to perceive high lifetime risk of breast cancer
compared to women in lower risk categories.
Women with FDRs affected by breast cancer had
higher perceived risk, particularly when those
relatives were their mother and sister.
Blalock, 1990
[14]
Observational,
cross-sectional
Colon 295 Grp 1 mean 56,
Grp 2 mean 59
M/F Race Self-perceived
heredity
Studied people with CRC-affected siblings and an
average risk comparison group. High risk
individuals were more likely to rate heredity as a
risk-increasing factor than as a risk-decreasing
factor, and whites in the high risk group were
more likely than blacks to rate heredity as a risk-
increasing factor.
Watson, 1999
[23]
Observational,
prospective
cohort
Breast 282 Median 37,
Range 19-76
F Having undergone
genetic counseling
Intrusive thoughts;
Cancer worry
Studied women with a FH of BC. Genetic
counseling produced a modest shift in the
accuracy of perceived lifetime risk of BC. Women
with a higher than average PR of BC were more
likely to report intrusive thoughts and cancer
worry.
Cunningham,
1998 [37]
Observational,
case-control
Breast 132 Grp 1 mean 50;
Grp 2 mean 49
F Cancer worry Studied women with benign breast problems and
a healthy comparison group. BC risk perceptions
were found to mediate differences between the
BBP and healthy comparison group in breast
cancer worry.
Miller, 2005
[42]
Observational,
prospective
cohort
Breast;
Ovarian
279 Mean 46 F Monitor status Studied women who expressed concerns about
their risk for BC or OC during self-initiated calls to
a Cancer Information Service. High monitors, who
typically attend to and seek information,
demonstrated greater increases in knowledge and
perceived risk over the 6-month interval than low
monitors.
Emery, 2007
[21]
Experimental Breast;
Colon;
Ovarian
246 - M/F Referral to a
genetics clinic
Studied patients referred to the Regional Genetics
Clinic by practices randomized to use either
Genetic Risk Assessment on the Internet with
Decision Support (GRAIDS) software or current
best practices. Patients who were not referred
from GRAIDS practices to the genetics clinic
showed lower mean risk perception than those
who were referred.
Bjorvatn, 2007
[20]
Observational,
cross-sectional
General
Cancer Risk
213 Mean 42, Range
18-80
M/F Undergoing
genetic counseling
Cancer worry Studied patients from genetic outpatient clinics of
three Norway hospitals. Perceptions of risk were
significantly reduced and more likely to be
accurate after genetic counseling compared to
before. After counseling, higher PR of developing
cancer was found to be correlated with higher
worry.
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5Table 2 Characteristics of 36 studies reporting clinical, demographic, and/or psychosocial factors related to cancer risk perception in high risk populations
not related to genetic susceptibility testing (Continued)
Quillin,
2006 [45]
Observational,
cross-sectional
Breast 899 Mean 50, SD 8 F + FH of cancer Race;
Education
Spiritual coping Studied women in the Women Improving
Screening Through Education & Risk Assessment
(WISER) study. Higher levels of spiritual coping
were associated with a lower perception of BC risk,
but only for women with a self-reported FH of
cancer. African-Americans were more likely to
perceive lower risk of BC than Caucasians.
Lipkus, 2006
[53]
Experimental Colon 160 Grp 1 mean 56;
Grp 2 mean 55;
Grp 3 mean 58;
Grp 4 mean 56
M/F Possession of
colorectal cancer
risk factors
Exposure to
different types risk
communi-cation;
ambivalence to
screening
Studied adults who were off-schedule for having a
fecal occult blood test. Participants who thought
they had more CRC risk factors reported greater
perceived absolute and comparative risk.
Cameron,
2006 [54]
Observational,
cross-sectional
Breast 303 Range 18-82;
Grp 1 mean 44;
Grp 2 mean 43;
Grp 3 mean 25
F +FH of breast
cancer
Worry Studied general practitioner clinic attenders,
university students, and FDRs of BC survivors. A
moderate correlation between perceived risk and
worry was found. FDRs of BC survivors reported
higher perceived risk than university students and
clinic attenders.
Madalinska,
2005 [55]
Observational,
cross-sectional
Breast 846 Grp 1 mean 49;
Grp 2 mean 47
F OC preventive
measures
Studied women at high risk of OC. PR of
developing BC was significantly lower among
women who had undergone prophylactic bilateral
salpingo-oophorectomy than women undergoing
gynecologic screening.
Cappelli, 2005
[10]
Observational,
case-control
Breast 110 Mean 16 F Family risk status Studied pairs of adolescent daughters whose
mothers had been treated for BC and daughters of
healthy mothers. Compared to adolescent
daughters of parents with no serious illnesses,
daughters of mothers with BC reported elevated
perceived risk of developing BC and an elevated
risk of having a BRCA mutation.
NOTE: Factors in italicized text indicate non-significant associations. Common abbreviations include PR = perceived risk; FH = family history; BC = breast cancer; CRC = colorectal cancer; OC = ovarian cancer; FDR =
first-degree relative.
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5Table 3 Characteristics of 17 studies reporting clinical, demographic, and/or psychosocial factors related to cancer risk perception in patients with
established genetic cancer susceptibility
First
author,
year
Design Cancer
Type
No.
sub-
jects
Age (years) Gender
M/F/ M
+F
Tested Factors Influencing Risk Perception Study Synopsis
Clinical Demographic Psychosocial
Domanska,
2007 [29]
Observational,
retrospective
cohort
Colon,
Endometrial
47 Mean 49,
Range 24-76
M+F Personal history of
cancer
Age;
Sex
Studied individuals with hereditary nonpolyposis
colorectal cancer-causing mutations who underwent
genetic counseling. Women and mutation carriers < 50
yrs reported highest PR for colon cancer. A personal
history of HNPCC-related cancers was not associated with
PR for colon cancer.
Cappelli,
2001 [9]
Observational Breast;
Ovarian
108 Grp 1 mean
40, Grp 2
mean 32
F ≥1 relative
diagnosed with BC
Studied women with ≥1 relative diagnosed with BC and
women from general population w/out cancer diagnosis.
Women in high risk group had a higher overall perceived
risk of getting cancer.
Peterson,
2008 [56]
Observational General
cancer risk;
p53 muta-
tion risk
92 Mean 50,
Range 18-81
M/F Cancer-specific distress Studied individuals from Li-Fraumeni syndrome families at
high risk of having a p53 mutation. Higher perceived risk
of cancer and having a p53 mutation was associated with
higher cancer-specific distress.
Codori,
2005 [33]
Observational,
prospective
cohort
Colon 101 Mean 44,
Range 18-81
M/F +FH of colorectal
cancer; Objective
risk of CRC;
Depressive
symptoms
Age; Sex;
Education
Level
Belief about
preventability of CRC;
Anxiety; Coping Style;
Tolerance for Ambiguity
Studied adults with ≥ 1 relative diagnosed with CRC who
received genetic counseling. Lower PR was associated
with being older, having higher objectively estimated risk,
having few or many FDRs with CRC, and beliefs about the
preventability of CRC. A borderline association between
PR and anxiety was also found.
Claes, 2004
[57]
Observational,
prospective
cohort
Colon;
Endometrial
40 Grp 1 mean
41, Grp 2
mean 43
M/F Distress Studied patients who had a test for HNPCC. Perceived risk
of CRC was not found to be associated with intrusion &
avoidance measures in a distress scale.
Bruno,
2004 [58]
Observational,
cross-sectional
Breast 677 Mean 45,
range 23-78
F +FH of breast or
ovarian cancer
Studied women attending an outpatient cancer
screening/prevention clinic in Italy. Only a minority
perceived having a higher personal risk of BC than their
peers, though this number was significantly higher in
women with a FH of BC than those without one.
Van Dijk,
2003 [18]
Observational Breast 241 < 30: 16%
30-39: 27%
40-49: 33%
50+: 25%
F Objective risk;
Having undergone
genetic counseling
Studied women with personal or FH of BC and the
impact of genetic counseling on perceived risk and worry.
Undergoing genetic counseling resulted in more accurate
perceptions of risk for breast cancer. Women with a
higher PR for BC reported stronger intention to undergo
prophylactic mastectomy.
Hensley,
2003 [59]
Observational Ovarian 147 Median 47,
Range 30-78
F Menopausal status Studied women at high risk for OC enrolling in a
screening study. Premenopausal women were more likely
than postmenopausal women to consider themselves at
higher risk of ovarian cancer. When comparing themselves
to others with similar family history, postmenopausal
women considered themselves at higher risk for ovarian
cancer.
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5Table 3 Characteristics of 17 studies reporting clinical, demographic, and/or psychosocial factors related to cancer risk perception in patients with estab-
lished genetic cancer susceptibility (Continued)
Di
Prospero,
2001 [24]
Observational Breast;
Ovarian
16 Mean 55,
Range 39-83
M/F Receipt of BRCA1/2
genetic test results
Studied individuals who received positive BRCA1/2 test
results. Cancer risk perception increased after receipt of
genetic test results.
Bratt, 2000
[41]
Observational,
cross-sectional
Prostate 110 40-49: 35%;
50-59: 36%;
60-69: 27%;
70-72: 2%
M Number affected
family members/
deceased relatives
Cancer worry;
Depression
Studied unaffected men with a pedigree consistent with
hereditary prostate cancer. PR of cancer was positively
correlated with both the number of prostate cancer-
affected and deceased members in men’s families. PR was
also associated with symptoms of depression and cancer
worry.
Codori,
1999 [17]
Observational,
cross-sectional
Colon 258 Grp 1
median 44,
Grp 2
median 50
M/F Acceptance of
genetic testing
Frequency of thoughts
about CRC
Studied FDRs of patients with CRC. Those who accepted
HNPCC testing had higher perceived risk compared to
those who declined. The association between risk
perception and uptake was dependent on frequency of
cancer thoughts.
Rimes,
2006 [15]
Observational,
prospective
cohort
Breast;
Colon;
Ovarian
218 Mean 39, SD
10
M/F +FH of cancer Age Anxiety Studied people with a FH of colon or breast and/or
ovarian cancer. Those with a FH of colon cancer had
lower PR of developing cancer than people with a FH of
BC and/or OC. Younger age predicted greater PR of
developing cancer. Before receiving genetic counseling,
higher anxiety was associated with higher PR of cancer.
Schwartz,
2000 [46]
Observational,
prospective
cohort
Breast;
Ovarian
290 < 45 years:
31%
F BRCA1/2 test
‘uptake’
Spirituality/
Faith
Studied adult BC patients who had self-referred to the
Cancer Assessment and Risk Evaluation Clinic at a cancer
center. PR for BC and OC was found to be associated with
patients’ decision to undergo BRCA1/2 testing. This
association was found to be modified by patients’ degree
of spirituality.
van
Oostrom,
2007 [60]
Observational,
prospective
cohort
Breast;
Colon;
Ovari
an
271 Grp 1 mean
43; Grp 2
mean 41
M/F Familial mutation
type (HNPCC v.
BRCA1/2); Mutation
carrier status
Studied individuals undergoing genetic testing for a
familial BRCA1/2 mutation or mutation predisposing to
HNPCC. There were no differences between BRCA1/2 and
HNPCC families in levels of perceived risk. For both
groups, actual carriers reported greater perceived risk after
disclosure of a positive test result.
O’Neill,
2006 [44]
Observational,
prospective
cohort
Breast;
Ovarian
64 Mean 57,
Range 36-80
F Distress;
Intolerance for
uncertainty
Studied women with FH of BC who received
uninformative BRCA1/2 results. 6 months after test result
disclosure, patients who perceived an elevated BC risk and
who difficulty coping with uncertainty reported high
levels of ongoing distress.
Matloff,
2006 [12]
Experimental Breast 48 Mean 49,
Range 41-55
F Objective risk; Use of
hormone therapy
Cancer Worry Studied menopausal women with ≥1 FDR with BC, some
of whom received a personalized risk assessment
intervention. Perceived risk and worry were significantly
positively correlated at 6 mos follow-up.
Martin,
2006 [11]
Observational,
retrospective
cohort
Breast 56 Mean 44,
Range 23-71
F Number of relatives
with BC;
Age; Education
Level
Depressive symptoms Studied women with a FH of BC. Age and education level
were not found to be significantly associated with
perceived risk of breast cancer. However; there was a
slight trend toward a higher score on the depressive
symptoms scale with a higher level of PR.
NOTE: Factors in italicized text indicate non-significant associations. Common abbreviations include PR = perceived risk; FH = family history; BC = breast cancer; CRC = colorectal cancer; OC = ovarian cancer; FDR =
first-degree relative.
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5continuous variables, and in some cases asked patients
to estimate their absolute risk while in others partici-
pants were asked to compare their risk to a relevant
comparison group (comparative risk). Thirty-seven stu-
dies used a single item measure of risk perception, 11
used two measures, three used three measures, and one
study used four measures. Twenty-two studies assessed
accuracy of risk perception. Of these, six were in studies
where subjects had undergone some kind of genetic
testing. We provide further details of risk perception
measures in an accompanying appendix (see Additional
file 1: Appendix).
Only 7 studies in our review referenced a specific the-
oretical model of health behavior as motivating or
informing their research. These included the health
belief model [9-13], the theory of planned behavior/the-
ory of reasoned action [12,14], the cognitive behavioral
model of health anxiety [15], and the precaution adop-
tion model [16].
The major clinical, demographic, and psychosocial fac-
tors influencing risk perception in patient populations at
high risk for cancer are described below. Tables 2 and 3
show results of the review stratified by risk perception
in those who had not undergone genetic susceptibility
testing as well as risk perception in those who had
undergone such testing. Any differences between groups
are discussed in the text.
Clinical Factors 
Cancer 
experience 
-family
-personal 
-cancer type 
Health
behaviors
-smoking 
-alcohol
Other 
conditions
-menopause 
status
Objective 
risk
 - risk 
assessment 
- genetic test 
Cognitive
-less 
preventable 
-lower
numeracy 
-serious cancer 
-awareness of 
hereditary risk 
Affective
-distress 
-anxiety
-worry 
-intrusive 
thoughts 
+avoidance 
-fear cancer 
Personality/ 
Motivational
-low internal 
LOC
-monitoring 
-punishment/ 
reward 
sensitivity
Cultural
e.g. spiritual coping, spiritual faith  
Perceived 
Risk
ble
-lower
numeracy
-serious cancer 
-awareness of 
ry r
-worry
-intrusive 
thoughts 
id
LOC
-monitoring 
-punishment/ 
d
Behavior
Demographic  
Factors 
Psychosocial Factors 
Education 
? marital 
status
? employed 
- younger 
age
?ethnicity/ 
race 
?gender 
Figure 1 Interrelated factors associated with cancer risk perception. Conceptual model of factors thought to be associated with perceived
risk for cancer.
Excluded after abstract screening (n=524) 
Articles selected for full text retrieval (n=504) 
Studies that fulfilled inclusion criteria (n=184)
Unobtainable full text of study (n=6) 
Excluded after full-text screening (n=312) 
• Non-original studies e.g. reviews, letters, etc. (n=39)  
•Outcomes of interest not reported (274) 
Studies included with persons at a 
high risk for cancer (n=53) 
Excluded because of irrelevant patient populations 
(n=131)
•Exclusively qualitative studies (n=24) 
•General population/average risk (n=95) 
•Healthcare providers (n=3) 
•Communities (n=5) 
•Already diagnosed with cancer (n=4) 
Potentially relevant studies identified by        
search (n=1028) 
Figure 2 Study selection process. Flow diagram of how research
studies were screened and selected.
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A variety of clinical factors were associated with cancer
risk perception. The most common association included
a family history of cancer or precancerous lesions (n =
11). Others included type of cancer [3], objective cancer
risk (e.g. from the Gail Model) [17-19], having received
genetic counseling or written documentation of genetic
testing results [20-23], and family history of death from
the cancer of interest [19]. Clinical factors influencing
risk perception among those who had undergone
genetic susceptibility testing focussed primarily on the
extent to which having undergone testing itself was a
predictor of risk perception [17,18,24]. In several studies
of patients with strong family history but no genetic
testing, the retrospective observation of having under-
gone screening, prophylactic surgery, or biopsy was
associated with risk perception [25-27].
Demographic factors
Age
Ten studies examined associations between age and risk
perception with variable findings. For instance, Rimes
et al found that, among those with a family history of
colon cancer, younger age predicted greater perceived
risk of developing cancer [15]. Likewise, Lerman et al
found that women in the 30-34 and 50+ categories were
less likely to perceive themselves as having an elevated
risk than were women in other age groups [28]. No stu-
dies tested the association between age and accuracy of
risk perception.
Gender
Just two studies examined associations between gender
and risk perception. Domanska noted that men and
women differed in the proportions of those who per-
ceived their lifetime risk of colorectal cancer as being
greater than 60%, but these differences were not signifi-
cant [29]. Since only 20% of all the studies focused on
risk perception of non gender-specific cancers, there
was minimal opportunity to evaluate the role of gender
in cancer risk perception.
Race/Ethnicity
Only four studies explored the relationship between
race/ethnicity and risk perception. Haas found that
black women were less likely than white women to
accurately perceive risk [30]; Mellon found that being
Caucasian was associated with higher risk perception
[3]; Blalock found that whites in a high risk group were
more likely than blacks in the same group to rate her-
edity as a risk-increasing factor [14]. Others tested but
did not find significant associations between race/ethni-
city and risk perception [31,32].
Other Demographic Factors
Some studies also tested for associations between other
demographic factors and cancer risk perception. Rowe
tested but did not find any association between marital
status, employment status and risk perception [31],
while Glanz et al found that having a college education
was directly associated with higher colorectal cancer risk
perception [16].
Psychosocial Factors
In addition to clinical and demographic factors that may
influence risk perception, several key psychosocial fac-
tors were also identified. These include cognitive, affec-
tive, as well as personality and coping factors.
Cognitive
Beliefs about the nature of the participant’s condition
and its preventability were occasionally examined.
Codori found that those who believed colorectal cancer
was less preventable expressed a higher perceived risk of
the disease [33]. Degree of awareness of one’s family his-
tory or the hereditary nature of one’s risk were also
positively associated with risk perception [14,16].
Affective
Distress, anxiety and worry have been consistently asso-
ciated with risk perception in multiple studies. Lebel
found that overestimation of risk was associated with
greater distress among those undergoing biopsy of
breast lesions [34]. Audrain studied women with a
family history of breast or ovarian cancer and found
similar results [35].
Some studies (n = 3) examined the association
between risk perception and existing measures of dis-
tress including the Impact of Events Scale (with the
intrusion and avoidance subscales) [19,36,37], and the
Total Mood Disturbance scale from the Profile of Mood
States (POMS-TMD) [38]. Andrykowski showed a nega-
tive association between perceived risk and avoidance
among women who had undergone biopsy [36]. That is,
the greater the perceived risk, the less propensity for
avoidance behavior. In contrast, Zakowski found that
those whose parents had died of cancer had the highest
levels of intrusive thoughts, avoidance and perceived
risk [19].
Vernon’s study of men at high risk of colorectal can-
cer [27] and Collins’ study of patients presenting at a
genetic testing clinic [39] showed that perceived risk
was directly associated with worry about being diag-
nosed with colorectal cancer. Rimes, Beebe-Dimmer,
and Bratt came to similar conclusions with analogous
affective measures [15,40,41].
Personality and Coping
A few studies showed that the encoding pattern of
“monitoring,” (i.e., scanning for, attending to, and ampli-
fying cancer threats) [42,43] as well as specific coping
styles [33,44] were also correlated with higher risk per-
ception. Finally, two studies showed an inverse relation-
ship between spirituality/spiritual coping and risk
Tilburt et al. Hereditary Cancer in Clinical Practice 2011, 9:2
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between belief systems and interpretation of risk.
Discussion
In this systematic review of 53 studies of patients at
high risk for cancer we identified several key clinical,
demographic, and psychosocial factors associated with
perceived risk of acquiring cancer in these patient popu-
lations. These are depicted in Figure 1. These results
highlight known and unknown factors related to the
science of risk perception assessment in patients at
higher than average risk for cancer.
Most of the studies evaluated in this review used an
observational design studying mostly women and their
perceived risk of developing breast or ovarian cancer
often in the context of genetic testing. In contrast, little
literature was found on factors influencing risk percep-
tion of acquiring other common cancers such as pros-
tate and colorectal cancer. Clinical factors associated
with cancer risk perception included the extent of family
history, as well as previous preventive tests and treat-
ments. Demographic factors including age, race/ethni-
c i t y ,a n de d u c a t i o nl e v e lm a yp l a yar o l ei nr i s k
perception. No studies were designed to assess factors
influencing risk perception in a prospective and strati-
fied manner for groups such as ethnic minorities or
elderly populations.
Based on this literature, cognitive factors including
beliefs about the preventability and severity of the condi-
tion, as well as the ability to process numerical informa-
tion may be important in risk perception. We also
observed consistently reported associations between
affective factors such as distress, depression, worry and
risk perception. These are perhaps the best characterized
factors influencing cancer risk perception in high risk
patients. A limited number of personality and coping fac-
tors may also relate to risk perception.
Our findings complement those of previous systematic
reviews by highlighting the strides taken in describing key
factors influencing cancer risk perception, especially affec-
tive factors. Like Vernon, we focused on key cognitive and
affective correlates of cancer risk perception in hopes that
a more complete description of such factors could empiri-
cally inform future interventions. Unlike Vernon, we
focused on groups at high risk, believing the specific needs
of these populations are under-explored, increasingly sali-
ent, and distinct from the general population. Katapodi
found weak but significant associations between perceived
risk and age, education, race, and worry; our findings five
years later across multiple cancers demonstrate analogous
associations. Each of these domains deserves further
exploration in longitudinal and experimental studies.
T h e s ed a t as u g g e s ts e v e r a ll i m i t a t i o n so ft h ec u r r e n t
literature on cancer risk perception among those with a
potential inherited predisposition to cancer. Taking the
next step in improving the measurement of risk percep-
tion such as better discriminating between the merits of
rating comparative risk versus estimating objective risk
could help standardize the cancer risk perception litera-
ture. Another limitation to current conceptions of risk
relates to current modes of measurement which are gen-
erally uni-dimensional (i.e. measuring magnitude or fre-
quency of risk, but not both) and/or contain only single
item measures. Multi-dimensional measures that capture
frequency, magnitude, as well as individual- and social-
level aspects of risk perception need to be developed
and utilized. In addition, few studies employed sophisti-
cated measurement or analytic techniques like latent
variable modeling, path analysis, or the like. Along with
experimental study designs in which investigators would
specify a priori hypothesized relationships and the direc-
tion of those relationships, these techniques would pro-
vide a sound basis for causal inferences related to risk
perception research to be made.
Finally, this systematic review did not identify poten-
tial rich networks of social and behavioral influences
t h a tm a yc a u s es o m ep e r s o n st od e e p l ye n g a g ew i t h
their risk, while others seem to push it aside. Such
dynamics related to the salience of perceived risk infor-
mation would be important to address in more sophisti-
cated analyses that contextualize risk in the broad fabric
of patients’ lives and social networks.
Clinical Implications
Research defining correlates of perceived risk of acquir-
ing cancer among those with elevated cancer suscept-
ibility suggest several clinical implications. Interventions
to address perceived risk of developing cancer among
high risk populations should not only rely on facts
about clinical and demographic characteristics, but also
on the real psychosocial factors that may influence risk
perception for those at high risk for cancer. Risk percep-
tion is not merely a cognitive process, but an affective
and existential one. The relationship between worry and
risk perception that we so consistently observed suggests
that worry may influence screening behaviors among
high risk patients regardless of the whether sound evi-
dence exists for the clinical utility of those screening
tests, such as in the case of direct-to-consumer genomic
testing. This creates tensions for practicing clinicians
who strive to judiciously utilize tests in a manner con-
sistent with the best available evidence and the patient’s
values. Risk perception is an unavoidably affectively-
loaded filter and is thus quite susceptible to manipula-
tion and distortion, making approaches to informed
decision-making that acknowledge and work in concert
with these influences in high risk populations especially
challenging and necessary.
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Overall, these data suggest that the science of characterizing
and improving risk perception in cancer, although evolving,
is still relatively undeveloped at least in several key clinical
topic areas. First, future studies focusing on cancer risk per-
ception among men, racially/ethnically diverse populations
that experience cancer disparities and the elderly would add
considerable value to the literature. Research dedicated to
risk perception related to specific topics such as adoption of
lifestyle behaviors, the use of complementary/integrative
medicine, genomic technologies in prediction and prognos-
tication, or participation in research studies including che-
moprevention would have potentially wide-reaching
implications for cancer control initiatives.
Additional material
Additional file 1: Appendix. Table showing details about risk
perception measures used in reviewed studies.
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